Nanomedicine Market to Reach $393.04 Bn, Globally, by 2030 at 9.2% CAGR: Allied Market Research

Increase in R&D activities regarding nanorobots and significant investments in clinical trials by the government as well as private sector drive the growth of the global nanomedicine market.

News provided by

Allied Market Research

Mar 15, 2022, 03:30 ET

PORTLAND, Ore., March 15, 2022 /PRNewswire/ -- Allied Market Research published a report, titled, "Nanomedicine Market by Modality (Diagnostics and Treatment), Application (Drug Delivery, Diagnostic Imaging, Vaccines, Regenerative Medicine, Implants, and Others), and Indication (Clinical Oncology, Infectious Diseases, Clinical Cardiology, Orthopedics, Neurology, Urology, Ophthalmology, Immunology And Others): Global Opportunity Analysis and Industry Forecast, 2021–2030." According to the report published by Allied Market Research, the global nanomedicine market was estimated at $171.69 billion in 2020 and is expected to hit $393.04 billion by 2030, registering a CAGR of 9.2% from 2021 to 2030.

For Right Perspective, Download Sample Report at: https://www.alliedmarketresearch.com/request-sample/2021

Drivers, restraints, and opportunities-

Increase in R&D activities regarding nanorobots and significant investments in clinical trials by the government as well as private sector drive the growth of the global nanomedicine market. On the other hand, the long approval process and several risks associated with nanomedicines (environmental impact) impede the growth to some extent. However, rise in out-licensing of nanodrugs and developments in healthcare facilities in the emerging economies are expected to create lucrative opportunities in the industry.

Covid-19 Scenario-

The outbreak of the pandemic gave way to steep increase in demand for nanomedicines for treatment of an array of diseases. Applications of nanomedicine offered new opportunities for development of novel products for prevention, diagnosis, and treatment of COVID-19 virus and other viral infections. This, in turn, impacted the global nanomedicine market positively.
This is trend is most likely to continue post pandemic as well.

The clinical oncology segment to dominate by 2030-

By indication, the clinical oncology segment contributed to the lion's share in 2020, holding nearly one-third of the global nanomedicine market, owing to the advancements made in the nanomedicine sphere and increase in awareness of nanomedicines in the area of nanotechnology. However, the neurology segment is projected to manifest the fastest CAGR of 10.7% from 2021 to 2030. This is attributed to the significant investments in clinical trials by the government as well as private bodies.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert: https://www.alliedmarketresearch.com/purchase-enquiry/2021

The treatments segment to retain the lion's share-

By modality, the treatments segment held the major share in 2020, garnering more than four-fifths of the global nanomedicine market. Increase in the prevalence of diseases such as cancer and COVID-19 virus and surge in awareness of nanomedicines applications propel the growth of the segment. The diagnostics segment, on the other hand, is projected to cite the fastest CAGR of 10.2% throughout the forecast period. Rise in number of oncology diseases and increase in disposable income fuel the segment growth.

North America Nanomedicine Market held the major share in 2020-

By region, North America dominated in 2020, garnering nearly two-fifths of the global nanomedicine market. Availability of advanced healthcare facilities along with trained medical professionals drives the market growth in the region. The market across Asia-Pacific, simultaneously, is expected to cite the fastest CAGR of 11.2% throughout the forecast period. Surge in incidence of various diseases and rise in R&D investments in the developing countries such as Japan and China accelerate the market growth.

Key players in the industry-

Mallinckrodt plc.
DiaSorin S.p.A.
Johnson & Johnson
General Electric Company
Invitae Corporation
Leadient BioSciences Inc.
Merck & Co., Inc.
Pfizer Inc.
Teva Pharmaceuticals Ltd.
Abbott Laboratories

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter

"We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market."

Trending Reports in Healthcare Industry (Book Now with 10% Discount):

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
[email protected]
Web: https://www.alliedmarketresearch.com/reports-store/life-sciences
Follow Us on LinkedIn: https://www.linkedin.com/showcase/life-sciences-industry-research/